Participants in clinical trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Diseases22

Neoplasms HIV Infections Disease Progression Chronic Disease Stroke Cardiovascular Diseases Breast Neoplasms Recurrence Pain Obesity Diabetes Mellitus, Type 2 Weight Loss Substance-Related Disorders Hypertension Diabetes Mellitus Lung Neoplasms Acute Disease Overweight Fatigue Dementia Alzheimer Disease Drug-Related Side Effects and Adverse Reactions

Chemicals and Drugs10

Placebos Antineoplastic Agents Biological Markers Drugs, Investigational Drug Combinations Anti-HIV Agents Antihypertensive Agents Antibodies, Monoclonal Blood Glucose Antibodies, Monoclonal, Humanized

Analytical, Diagnostic and Therapeutic Techniques and Equipment96

Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Research Design Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Questionnaires Controlled Clinical Trials as Topic Prospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Patient Selection Risk Factors Pilot Projects Placebos Multicenter Studies as Topic Single-Blind Method Clinical Protocols Cross-Sectional Studies Cohort Studies Severity of Illness Index Reproducibility of Results Longitudinal Studies Clinical Trials, Phase IV as Topic Analysis of Variance Risk Assessment Early Termination of Clinical Trials Drug Therapy, Combination Drug Administration Schedule Sample Size Feasibility Studies Logistic Models Exercise Therapy Pain Measurement Interviews as Topic Cross-Over Studies Incidence Magnetic Resonance Imaging Combined Modality Therapy Multivariate Analysis Regression Analysis Focus Groups Program Evaluation Linear Models Data Interpretation, Statistical Predictive Value of Tests Data Collection Prognosis Endpoint Determination Body Mass Index Retrospective Studies Chi-Square Distribution Administration, Oral Odds Ratio Proportional Hazards Models Survival Analysis Activities of Daily Living Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Self Care Obesity Self Report Mass Screening Statistics, Nonparametric Therapeutic Human Experimentation Risk Confidence Intervals Human Experimentation Sensitivity and Specificity Survival Rate Disability Evaluation Random Allocation Statistics as Topic Meta-Analysis as Topic Phytotherapy Kaplan-Meier Estimate Drug Evaluation Disease-Free Survival Therapy, Computer-Assisted Blood Pressure Control Groups Drug Approval Geriatric Assessment Health Surveys Photic Stimulation Treatment Failure Overweight Intervention Studies Models, Statistical Physical Therapy Modalities Infusions, Intravenous Reference Values Pain Management Probability Muscle Strength

Psychiatry and Psychology56

Patient Compliance Health Knowledge, Attitudes, Practice Motivation Neuropsychological Tests Cognitive Therapy Depression Decision Making Cognition Focus Groups Psychiatric Status Rating Scales Smoking Attitude to Health Behavior Therapy Counseling Cognition Disorders Smoking Cessation Psychomotor Performance Pain Reaction Time Psychometrics Comprehension Motor Activity Health Behavior Risk Reduction Behavior Life Style Attention Affect Choice Behavior Substance-Related Disorders Stress, Psychological Attitude of Health Personnel Adaptation, Psychological Anxiety Emotions Communication Perception Depressive Disorder Self Efficacy Interpersonal Relations Self Concept Alcohol Drinking Judgment Disclosure Mental Recall Task Performance and Analysis Attitude Physician-Patient Relations Problem Solving Depressive Disorder, Major Awareness Dementia Alzheimer Disease Medication Adherence Cooperative Behavior Sexual Behavior Feedback, Psychological

Phenomena and Processes23

Time Factors Exercise Dose-Response Relationship, Drug Body Mass Index Chi-Square Distribution Odds Ratio Psychomotor Performance Pain Obesity Reaction Time Diet Pregnancy Motor Activity Weight Loss Walking Risk Sensitivity and Specificity Aging Blood Pressure Recovery of Function Overweight Probability Muscle Strength

Disciplines and Occupations9

Research Design Evidence-Based Medicine Biomedical Research Qualitative Research Outcome Assessment (Health Care)Therapeutic Human Experimentation Medical Oncology Human Experimentation Statistics as Topic

Anthropology, Education, Sociology and Social Phenomena18

Quality of Life Informed Consent Patient Education as Topic Exercise Activities of Daily Living Health Status Walking Health Education Social Support National Institutes of Health (U.S.)Drug Approval United States Food and Drug Administration Geriatric Assessment Universities Students Disclosure National Cancer Institute (U.S.)Demography

Technology, Industry, Agriculture2

Dietary Supplements Drug Industry

Humanities3

Quality of Life Ethics Committees, Research Ethics, Research

Information Science16

Questionnaires Interviews as Topic Incidence Internet Focus Groups Data Interpretation, Statistical Data Collection Self Report Survival Rate Communication Telephone Therapy, Computer-Assisted Geriatric Assessment Disclosure Publishing Feedback, Psychological

Named Groups9

Research Subjects African Americans Patient Dropouts Research Personnel European Continental Ancestry Group Infant, Newborn Hispanic Americans Students Ethnic Groups

Health Care111

Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Questionnaires Controlled Clinical Trials as Topic Prospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Patient Selection Risk Factors Pilot Projects Multicenter Studies as Topic Single-Blind Method Clinical Protocols Cross-Sectional Studies Clinical Trials Data Monitoring Committees Cohort Studies Severity of Illness Index Patient Compliance Reproducibility of Results Longitudinal Studies Clinical Trials, Phase IV as Topic Analysis of Variance Age Factors Health Knowledge, Attitudes, Practice Risk Assessment Informed Consent Early Termination of Clinical Trials Patient Participation Patient Education as Topic Sample Size Feasibility Studies Cost-Benefit Analysis Patient Satisfaction Logistic Models Interviews as Topic Cross-Over Studies Sex Factors Incidence Multivariate Analysis Regression Analysis Focus Groups Program Evaluation Linear Models Data Interpretation, Statistical Predictive Value of Tests Data Collection Placebo Effect Body Mass Index Retrospective Studies Chi-Square Distribution Odds Ratio Attitude to Health Proportional Hazards Models Survival Analysis Activities of Daily Living Counseling Health Promotion Case-Control Studies Outcome Assessment (Health Care)Self Care Self Report Mass Screening Health Status Intention to Treat Analysis Patient Acceptance of Health Care Statistics, Nonparametric Ethics Committees, Research Bias (Epidemiology)Risk Confidence Intervals Sensitivity and Specificity Survival Rate Comorbidity Ethics, Research Attitude of Health Personnel Health Education Random Allocation Primary Health Care Statistics as Topic Guidelines as Topic Meta-Analysis as Topic Educational Status Kaplan-Meier Estimate Disease-Free Survival National Institutes of Health (U.S.)United States Food and Drug Administration Geriatric Assessment Research Support as Topic Rural Population Patient Preference Safety Health Surveys Treatment Failure Intervention Studies Models, Statistical National Cancer Institute (U.S.)Ethnic Groups Residence Characteristics Pain Management Physician-Patient Relations Selection Bias Community Health Services Demography Probability Medication Adherence Urban Population Accidental Falls

Geographicals10

United States Great Britain Australia Canada Netherlands Europe New Zealand Germany Japan Ontario

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase III as Topic Research Design Clinical Trials, Phase II as Topic Double-Blind Method Clinical Trials, Phase I as Topic Questionnaires Controlled Clinical Trials as Topic Prospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Time Factors Patient Selection Risk Factors United States Pilot Projects Placebos Multicenter Studies as Topic Single-Blind Method Research Subjects Clinical Protocols Cross-Sectional Studies Neoplasms Clinical Trials Data Monitoring Committees Cohort Studies Quality of Life Severity of Illness Index Patient Compliance Reproducibility of Results Longitudinal Studies Clinical Trials, Phase IV as Topic Analysis of Variance Age Factors Health Knowledge, Attitudes, Practice Risk Assessment Informed Consent Early Termination of Clinical Trials Drug Therapy, Combination HIV Infections Patient Participation Antineoplastic Agents Patient Education as Topic Drug Administration Schedule Sample Size Feasibility Studies Motivation Cost-Benefit Analysis Patient Satisfaction Logistic Models Neuropsychological Tests Exercise Therapy Pain Measurement Evidence-Based Medicine Biomedical Research Interviews as Topic Cross-Over Studies Sex Factors Incidence Cognitive Therapy Biological Markers Internet Magnetic Resonance Imaging Combined Modality Therapy Multivariate Analysis Disease Progression Chronic Disease Depression Stroke Regression Analysis Decision Making Cognition Focus Groups Program Evaluation Dietary Supplements Linear Models Cardiovascular Diseases Data Interpretation, Statistical African Americans Predictive Value of Tests Exercise Data Collection Patient Dropouts Psychiatric Status Rating Scales Placebo Effect Prognosis Dose-Response Relationship, Drug Endpoint Determination Body Mass Index Retrospective Studies Breast Neoplasms Chi-Square Distribution Recurrence Administration, Oral Smoking Odds Ratio Attitude to Health Proportional Hazards Models Qualitative Research Great Britain

No FAQ available that match "participants in clinical trials"